Estimated costs of treatment-related adverse events (TRAEs) for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in the checkmate 141 trial

Autor:	James W. Shaw, I. Santi, M. Contente, Beata Korytowsky, Meena Venkatachalam, S. Bobiak, David D. Stenehjem
Rok vydání:	2017
Předmět:	Oncology medicine.medical_specialty business.industry 030503 health policy & services Checkmate Hematology 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine medicine Basal cell 0305 other medical science Adverse effect business Head and neck
Zdroj:	Annals of Oncology. 28:v378-v379
ISSN:	0923-7534
DOI:	10.1093/annonc/mdx374.013
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4427bff291626e6aa4e775f0d83eb0a9 https://doi.org/10.1093/annonc/mdx374.013 Zobrazit plný text záznamu